Your options: recalculate your dose based on the actual concentration, or discard and start fresh with a new vial
Neurochem Res 37:27062714 Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA, Cotman C, Cottrell B, Montine TJ, Thomas RG, Aisen P, Alzheimer's Disease Cooperative S (2012) Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures
This review highlights that given the robust preclinical evidence and high public interest, there is a critical need for well-designed human trials to assess the safety, efficacy, and clinical utility of BPC-157 in musculoskeletal medicine
8 The time-response data and dose-response data are presented as the number of flinches in each phase
Temperature Modulation of Integrin-Mediated Cell Adhesion
doi:10.1080/15563650600811607